Geode Capital Management
ARRY

Geode Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Geode Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,005,394
Closed -$139M – 4297
2019
Q2 		$139M Buy
3,005,394
+244,633
+9% +$6.87M 0.03% 482
2019
Q1 		$67.3M Buy
2,760,761
+266,035
+11% +$5.54M 0.02% 701
2018
Q4 		$35.5M Buy
2,494,726
+174,315
+8% +$2.64M 0.01% 913
2018
Q3 		$35.3M Buy
2,320,411
+139,860
+6% +$2.14M 0.01% 1018
2018
Q2 		$36.6M Buy
2,180,551
+198,940
+10% +$3.16M 0.01% 951
2018
Q1 		$32.3M Buy
1,981,611
+113,861
+6% +$1.82M 0.01% 959
2017
Q4 		$23.9M Buy
1,867,750
+83,705
+5% +$952K 0.01% 1146
2017
Q3 		$21.9M Buy
1,784,045
+284,867
+19% +$2.65M 0.01% 1163
2017
Q2 		$12.5M Sell
1,499,178
-66,974
-4% -$548K ﹤0.01% 1510
2017
Q1 		$14M Buy
1,566,152
+113,632
+8% +$1.21M 0.01% 1414
2016
Q4 		$12.8M Buy
1,452,520
+499,340
+52% +$3.67M 0.01% 1426
2016
Q3 		$6.43M Buy
953,180
+42,311
+5% +$164K ﹤0.01% 1809
2016
Q2 		$3.24M Buy
910,869
+26,919
+3% +$87.7K ﹤0.01% 2171
2016
Q1 		$2.61M Sell
883,950
-152,486
-15% -$457K ﹤0.01% 2269
2015
Q4 		$4.37M Buy
1,036,436
+170,189
+20% +$777K ﹤0.01% 1958
2015
Q3 		$3.95M Buy
866,247
+56,168
+7% +$333K ﹤0.01% 1991
2015
Q2 		$5.84M Buy
810,079
+2,705
+0.3% +$20K ﹤0.01% 1795
2015
Q1 		$5.95M Buy
807,374
+111,531
+16% +$794K ﹤0.01% 1762
2014
Q4 		$3.29M Buy
695,843
+114,894
+20% +$454K ﹤0.01% 2086
2014
Q3 		$2.07M Buy
580,949
+10,601
+2% +$41.8K ﹤0.01% 2341
2014
Q2 		$2.6M Buy
570,348
+6,567
+1% +$27.2K ﹤0.01% 2212
2014
Q1 		$2.65M Buy
563,781
+32,598
+6% +$164K ﹤0.01% 2168
2013
Q4 		$2.66M Buy
531,183
+11,389
+2% +$62K ﹤0.01% 2119
2013
Q3 		$3.23M Buy
519,794
+41,736
+9% +$248K ﹤0.01% 1880
2013
Q2 		$2.17M Buy
+478,058
New +$2.57M ﹤0.01% 1982

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Geode Capital Management's ARRY Position: Q3 2019 in Review

Geode Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 3,005,394 shares — an estimated $139M sold.

Geode Capital Management first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $139M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Geode Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Geode Capital Management sold 3,005,394 Array Biopharma Inc shares in Q3 2019, an estimated $139M.
  • Geode Capital Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Geode Capital Management's Array Biopharma Inc position peaked at $139M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Geode Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.